Veeco and Leica Integrate AFM and Microscope to Create BioScope II AFM

Veeco Instruments Inc., a leading provider of instrumentation to the nanoscience community, and Leica Microsystems GmbH, a leading designer and manufacturer of optical microscopy imaging systems, have finalized a product collaboration to drive research in biological and nano-medicine communities. The initial phase of the collaboration focuses on the integration of Veeco’s BioScope™ II Atomic Force Microscope (AFM) with Leica’s DMI series of inverted microscopes. The alliance will yield high-resolution images for cell biology, enabling researchers to uncover positive ways to impact human disease and treatment. Veeco and Leica Microsystems have debuted their collaboration at the AFM BioMed Conference in Barcelona, Spain, April 19-21 (www.afmbiomed.com) with a common marketing campaign.

“Veeco’s work with Leica Microsystems provides a powerful opportunity to move the bioscience community forward,” commented Francis Steenbeke, Veeco’s Vice President and Life Science business development manager. “Now researchers from all specialties can integrate AFM technology with optical fluorescence and confocal microscopes. This first step, which involves the integration of our instruments, will greatly improve the future of research in the bioscience community.”

The innovative, high-performance BioScope II AFM has been engineered specifically to facilitate advanced bioscience. The revolutionary design of the BioScope II enables novel in-situ techniques for measuring biological samples in three dimensions, and, when integrated with Leica’s DMI series of inverted optical or, at a later step, confocal microscopes, will give the live cell researcher an intelligent and coded instrument.

“With its leading technologies in high resolution confocal microscopy and its broad range of application-driven solutions in fluorescence light microscopy, Leica Microsystems provides an excellent basis for further expansions and combinations of optical microscopy and AFM technologies,” added Martin Haase, Business Unit Manager, Leica Compound Microscopy Systems. “This kind of collaboration underlines Leica’s strategy to further extend its innovative product offering by open innovation projects.”

The new integrated AFM optical microscope is appropriate for a wide-array of cutting-edge bioscience applications, such as spatial identification of protein molecules and cellular structures, investigations of cell response to mechanical stimulation and nano-manipulation, and in-situ pharmacological studies of live cells. By being able to mechanically probe and manipulate cellular samples without complicated preparation, biologists can have a unique view into cell functionality and are able to conduct experiments which were impossible with traditional microscopy techniques.

Mr. Steenbeke added, “This collaboration with Leica is the latest in a series of actions Veeco is taking to expand our commitment to the life science research community, which has included strengthening our life science engineering and applications support and partnering with global life science industry experts who can help guide us in our product development process.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Leica Microsystems GmbH. (2023, April 14). Veeco and Leica Integrate AFM and Microscope to Create BioScope II AFM. AZoNano. Retrieved on March 01, 2024 from https://www.azonano.com/news.aspx?newsID=4070.

  • MLA

    Leica Microsystems GmbH. "Veeco and Leica Integrate AFM and Microscope to Create BioScope II AFM". AZoNano. 01 March 2024. <https://www.azonano.com/news.aspx?newsID=4070>.

  • Chicago

    Leica Microsystems GmbH. "Veeco and Leica Integrate AFM and Microscope to Create BioScope II AFM". AZoNano. https://www.azonano.com/news.aspx?newsID=4070. (accessed March 01, 2024).

  • Harvard

    Leica Microsystems GmbH. 2023. Veeco and Leica Integrate AFM and Microscope to Create BioScope II AFM. AZoNano, viewed 01 March 2024, https://www.azonano.com/news.aspx?newsID=4070.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.